Cargando…
NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner
BACKGROUND: Ovarian cancer is the leading cause of death among gynecological cancers. Cisplatin is one of the most effective anticancer drugs used in the treatment of ovarian cancer. Development of resistance to cisplatin limits its therapeutic use. Most of the anticancer drugs, including cisplatin,...
Autores principales: | Shankar, Eswar, Basu, Chandreyi, Adkins, Brett, Siede, Wolfram, Basu, Alakananda |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889948/ https://www.ncbi.nlm.nih.gov/pubmed/20459745 http://dx.doi.org/10.1186/1750-2187-5-4 |
Ejemplares similares
-
Rad5 Template Switch Pathway of DNA Damage Tolerance Determines Synergism between Cisplatin and NSC109268 in Saccharomyces cerevisiae
por: Jain, Dilip, et al.
Publicado: (2013) -
Cellular Responses to Cisplatin-Induced DNA Damage
por: Basu, Alakananda, et al.
Publicado: (2010) -
Two Faces of Protein Kinase Cδ: The Contrasting Roles of PKCδ in Cell Survival and Cell Death
por: Basu, Alakananda, et al.
Publicado: (2010) -
ATR mediates cisplatin resistance in a p53 genotype-specific manner
por: Sangster-Guity, N, et al.
Publicado: (2011) -
NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis
por: Shi, Y, et al.
Publicado: (2015)